| Dr Ognjen Stevanovic, MD | |
|
175 Inverness Dr W Ste 200, Englewood, CO 80112-5069 | |
| (303) 694-3333 | |
| Not Available |
| Full Name | Dr Ognjen Stevanovic |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery - Sports Medicine |
| Location | 175 Inverness Dr W Ste 200, Englewood, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558802819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | DR.0068153 (Colorado) | Primary |
| Entity Name | Plymouth Bay Orthopedic Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548281488 PECOS PAC ID: 3375448335 Enrollment ID: O20060912000494 |
News Archive
Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.
According to South Australia Health authorities, 13 more people have fallen ill with salmonella that spread via three types of custard-filled pastries made in Adelaide. This brings the total number of ill people to 74 with 29 admitted to hospital with salmonella typhimurium phage type 9 infection. The custard-filled products from Vili's and St George Cakes and Gelati were recalled after being associated with the salmonella outbreak.
With the growing prevalence of chronic pain, depression, anxiety, and other symptom-based conditions, physicians and the healthcare systems for which they work are increasingly considering how to augment the care they can provide within the limited time allotted for patient appointments.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
According to a new study being published early online in Annals of Internal Medicine, the flagship journal of the American College of Physicians, birth cohort screening for hepatitis C is cost effective in the primary care setting.
› Verified 8 days ago
| Entity Name | Physicians Of Cape Cod Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679832364 PECOS PAC ID: 9638326671 Enrollment ID: O20120828000193 |
News Archive
Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.
According to South Australia Health authorities, 13 more people have fallen ill with salmonella that spread via three types of custard-filled pastries made in Adelaide. This brings the total number of ill people to 74 with 29 admitted to hospital with salmonella typhimurium phage type 9 infection. The custard-filled products from Vili's and St George Cakes and Gelati were recalled after being associated with the salmonella outbreak.
With the growing prevalence of chronic pain, depression, anxiety, and other symptom-based conditions, physicians and the healthcare systems for which they work are increasingly considering how to augment the care they can provide within the limited time allotted for patient appointments.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
According to a new study being published early online in Annals of Internal Medicine, the flagship journal of the American College of Physicians, birth cohort screening for hepatitis C is cost effective in the primary care setting.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ognjen Stevanovic, MD 251 E Huron St, Chicago, IL 60611-2908 Ph: (312) 926-2000 | Dr Ognjen Stevanovic, MD 175 Inverness Dr W Ste 200, Englewood, CO 80112-5069 Ph: (303) 694-3333 |
News Archive
Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.
According to South Australia Health authorities, 13 more people have fallen ill with salmonella that spread via three types of custard-filled pastries made in Adelaide. This brings the total number of ill people to 74 with 29 admitted to hospital with salmonella typhimurium phage type 9 infection. The custard-filled products from Vili's and St George Cakes and Gelati were recalled after being associated with the salmonella outbreak.
With the growing prevalence of chronic pain, depression, anxiety, and other symptom-based conditions, physicians and the healthcare systems for which they work are increasingly considering how to augment the care they can provide within the limited time allotted for patient appointments.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
According to a new study being published early online in Annals of Internal Medicine, the flagship journal of the American College of Physicians, birth cohort screening for hepatitis C is cost effective in the primary care setting.
› Verified 8 days ago
Dr. Judith Emily Kopinski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 Inverness Dr E Ste 300, Englewood, CO 80112 Phone: 303-695-6060 Fax: 303-369-7776 | |
John S Woodward Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 799 E Hampden Ave, Suite 400, Englewood, CO 80113 Phone: 303-789-2663 Fax: 303-788-4871 | |
Dr. Christopher Rolf Johnson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 145 Inverness Dr E Ste 100, Englewood, CO 80112 Phone: 303-697-7463 | |
Philip Heyman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 E Hampden Ave, Suite 500, Englewood, CO 80113 Phone: 303-744-7078 Fax: 303-744-0248 | |
Trevor Jordan Wait, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 175 Inverness Dr W, Englewood, CO 80112 Phone: 720-848-0000 | |
Dr. Steven J Morgan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 E Hampden Ave, Suite 515, Englewood, CO 80113 Phone: 303-209-2503 Fax: 303-761-0803 | |
James T Muffly, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 799 E Hampden Ave, Ste 310, Englewood, CO 80113 Phone: 303-788-7840 Fax: 303-788-7839 |